CUMBERLAND PHARMACEUTICALS (CPIX)

US2307701092 - Common Stock

1.68  -0.11 (-6.15%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
35.985M
-3.89%
42.011M
16.75%
39.553M
-5.85%
EBITDA
YoY % growth
-1.671M
-16.86%
123.18K
107.37%
-1.275M
-1,134.97%
EBIT
YoY % growth
-6.277M
-1.58%
-5.205M
17.08%
-6.211M
-19.33%
Operating Margin
-17.44%-12.39%-15.70%
EPS
YoY % growth
N/AN/A0.18

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2021
Q2Q % growth
0.00
-100.00%
-0.070.07100.00%
Q1 2021
Q2Q % growth
0.07
600.00%
-0.070.14198.04%
Q4 2020
Q2Q % growth
0.01
-88.89%
-0.010.02198.04%
Q3 2020
Q2Q % growth
0.02
100.00%
-0.070.09128.01%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2021
Q2Q % growth
9.055M
-5.67%
8.742M313.48K3.59%
Q1 2021
Q2Q % growth
10.54M
26.53%
8.673M1.867M21.53%
Q4 2020
Q2Q % growth
10.26M
10.20%
9.978M282K2.83%
Q3 2020
Q2Q % growth
9.25M
33.29%
8.786M464K5.28%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A